Metabolic and endocrine effects of sedative agents
نویسندگان
چکیده
منابع مشابه
Metabolic and endocrine effects of sedative agents.
Metabolically critical illness can be divided in two phases, acute and prolonged. Whereas the acute or hypermetabolic phase is characterized by elevated circulating concentration of catabolic hormones and substrate utilization to provide energy to vital organs, the prolonged or catabolic phase of critical illness is marked by reduced endocrine stimulation and severe loss of body cell mass. The ...
متن کاملELDERLY STUDIES AT THE INSTITUTE OF ENDOCRINE AND METABOLIC SCIENCES
Background: Identifying the risk factors for the health of the elderly and designing interventions to improve the health of the elderly is one of the priorities of the health care system in the world today. This first requires the promotion of scientific knowledge in the field of health problems of the elderly. Methods: In this review conducted in 1399, all studies with the keyword of aging or...
متن کاملMetabolic and endocrine effects of metabolic acidosis in humans.
Metabolic acidosis is an important acid-base disturbance in humans. It is characterised by a primary decrease in body bicarbonate stores and is known to induce multiple endocrine and metabolic alterations. Metabolic acidosis induces nitrogen wasting and, in humans, depresses protein metabolism. The acidosis-induced alterations in various endocrine systems include decreases in IGF-1 levels due t...
متن کامل155 - Sedative-Hypnotic Agents
Barbiturates were formerly the primary sedative-hypnotic agents used clinically. Currently, they are most often encountered as anticonvulsants, induction agents for anesthesia, and agents used for procedural sedation. Because the barbiturates have largely been replaced clinically by benzodiazepines due to safety concerns, their prevalence in overdoses has drastically decreased when compared wit...
متن کاملEffects of Sedative Medicines
تا سال ۱۹۵۰ داروی اختصاصی برای درمان نشانه های سایکوتیک در دسترس نبود. در سال ۱۹۵۲ برای اولین بار داروی کلرپرومازین در یک بیمارستان ارتش در حومه پاریس تجویز شد. دو سال بعد این دارو با نام «لارگاکتیل» در فرانسه مورد استفاده قرار گرفت. نام این دارو بازتابی از اثرات وسیع آن می باشد. کلرپرومازین با داروهای خواب آور ابتدایی مثل هیدرات کلرال و باربیتوراتهاه متفاوت بود، زیرا اثراتی بیش از خواب آوری دا...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Opinion in Critical Care
سال: 2005
ISSN: 1070-5295
DOI: 10.1097/01.ccx.0000166397.50517.1f